@article{3182161,
    title = "The Believe Trial: Results of a Phase 3, Randomized, Double-Blind,
Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia
Patients Who Require Regular Red Blood Cell (RBC) Transfusions",
    author = "Cappellini, Maria Domenica and Viprakasit, Vip and Taher, Ali and and Georgiev, Pencho and Kuo, Kevin H. M. and Coates, Thomas D. and and Voskaridou, Ersi and Liew, Hong Keng and Pazgal-Kobrowski, Idit and and Forni, Gianluca and Perrotta, Silverio and Khelif, Abderrahim and Lal, and Ashutosh and Kattamis, Antonis and Vlachaki, Efthymia and Origa, and Raffaella and Aydinok, Yesim and Bejaoui, Mohamed and Ho, P. Joy and and Chew, Lee Ping and Bee, Ping Chong and Lim, Soo Min and Lu, Meng-Yao and and Tantiworawit, Adisak and Ganeva, Penka and Gercheva, Liana and Shah, and Farrukh and Neufeld, Ellis J. and Laadem, Abderrahmane and Shetty, and Jeevan K. and Zou, Jun and Miteva, Dimana and Zinger, Tatiana and Linde, and Peter G. and Sherman, Matthew L. and Hermine, Olivier and Porter, John and and Piga, Antonio",
    journal = "Blood advances",
    year = "2018",
    volume = "132",
    number = "1",
    publisher = "AMER SOC HEMATOLOGY",
    doi = "10.1182/blood-2018-163"
}